The Off-Target Effects, Electrolyte and Mineral Disorders of SGLT2i

The sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a relatively new class of antidiabetic drugs that, in addition to emerging as an effective hypoglycemic treatment, have been shown to improve, in several trials, both renal and cardiovascular outcomes. In consideration of the renal site of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cianciolo, Giuseppe, De Pascalis, Antonio, Gasperoni, Lorenzo, Tondolo, Francesco, Zappulo, Fulvia, Capelli, Irene, Cappuccilli, Maria, La Manna, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355461/
https://www.ncbi.nlm.nih.gov/pubmed/32549243
http://dx.doi.org/10.3390/molecules25122757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355461/
https://www.ncbi.nlm.nih.gov/pubmed/32549243
http://dx.doi.org/10.3390/molecules25122757

Ejemplares similares